Human tumour vessel heterogeneity in ovarian cancer and its association with response to neoadjuvant chemotherapy
Clin Transl Med
.
2024 Apr;14(4):e1633.
doi: 10.1002/ctm2.1633.
Authors
Emmanuel M Gabriel
1
,
Kulkaew Sukniam
2
,
Kyle Popp
3
,
Gabrielle Kowkabany
4
,
Harsheen K Manaise
5
,
Kristopher Attwood
6
,
Anthony George
6
,
Qihui Zhai
7
,
Sanjay P Bagaria
1
,
Keith L Knutson
8
,
Joseph J Skitzki
9
,
Matthew W Robertson
10
,
Tri A Dinh
10
Affiliations
1
Department of General Surgery, Division of Surgical Oncology, Mayo Clinic, Jacksonville, Florida, USA.
2
Department of Surgery, Philadelphia College of Osteopathic Medicine, Suwanee, Georgia, USA.
3
Department of Biology, Florida State University, Tallahassee, Florida, USA.
4
Department of Chemical Engineering, University of Alabama, Tuscaloosa, Alabama, USA.
5
Department of Medicine, Government Medical College and Hospital, Chandigarh, India.
6
Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
7
Department of Pathology, Mayo Clinic, Jacksonville, Florida, USA.
8
Department of Immunology, Mayo Clinic, Jacksonville, Florida, USA.
9
Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
10
Department of Gynecological Oncology, Mayo Clinic, Jacksonville, Florida, USA.
PMID:
38616706
PMCID:
PMC11016937
DOI:
10.1002/ctm2.1633
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Female
Humans
Neoadjuvant Therapy*
Ovarian Neoplasms* / drug therapy
Grants and funding
KL2 TR002379/TR/NCATS NIH HHS/United States
P30 CA016056/CA/NCI NIH HHS/United States